follow
spillov
zoonot
sourc
filovirus
transmit
persontoperson
direct
contact
infecti
bodili
fluid
result
larg
outbreak
viral
hemorrhag
fever
high
case
famili
filovirida
includ
two
genera
virus
known
caus
diseas
human
andor
nonhuman
primat
genu
marburgviru
includ
one
viru
speci
compris
two
virus
marburg
viru
ravn
viru
genu
ebolaviru
includ
six
viru
speci
compris
one
viru
ebola
viru
bundibugyo
viru
forest
viru
sudan
viru
reston
viru
bombali
viru
except
bombali
marburgvirus
ebolavirus
caus
outbreak
viral
hemorrhag
fever
subsaharan
reston
viru
caus
diseas
nonhuman
primat
circul
appear
limit
philippin
far
less
known
bombali
viru
genom
viral
rna
recent
detect
angolan
freetail
bat
mop
condyluru
littl
freetail
bat
chaerephon
pumilu
sierra
date
bombali
viru
reportedli
isol
sinc
discoveri
marburg
viru
mani
index
case
marburgviru
diseas
report
enter
batinhabit
cave
underground
mine
prior
becom
retrospect
investig
three
outbreak
marburgviru
diseas
among
miner
work
goroumbwa
mine
northeastern
democrat
republ
congo
drc
miner
work
kitaka
mine
southwest
uganda
two
tourist
separ
visit
nearbi
python
cave
uganda
reveal
locat
inhabit
larg
popul
egyptian
rousett
bat
erb
rousettu
aegyptiacu
longitudin
ecolog
investig
later
identifi
bat
speci
natur
reservoir
host
marburgvirus
sourc
viru
emerg
unlik
spillov
event
lead
marburgviru
diseas
ebolaviru
diseas
difficult
associ
specif
environ
cave
furthermor
evid
link
ebolaviru
spillov
particular
speci
bat
larg
circumstanti
exampl
index
case
sudan
viru
diseas
work
cotton
factori
sudan
retrospect
investig
eight
nine
month
initi
outbreak
identifi
larg
roof
coloni
trevor
freetail
bat
mop
trevori
directli
work
area
index
put
index
case
ebola
viru
diseas
outbreak
provinc
drc
said
purchas
bat
consumpt
follow
report
annual
migrat
hammerhead
bat
hypsignathu
monstrosu
franquet
epaulet
fruit
bat
epomop
franquetti
lastli
presum
index
case
ebola
viru
diseas
outbreak
start
guinea
report
play
tree
hollow
dna
trace
mop
condyluru
later
major
research
direct
toward
identif
natur
reservoir
host
ebolavirus
consist
crosssect
surveil
subsaharan
african
asian
bat
popul
evid
activ
past
ebolaviru
infect
predomin
crosssect
studi
attribut
larg
number
bat
speci
resid
within
geograph
rang
ebolaviru
circul
requir
investig
well
challeng
associ
obtain
diagnost
specimen
mammal
difficult
captur
due
elus
nocturn
natur
abil
fli
collect
ebola
viru
rna
detect
three
bat
speci
captur
republ
congo
gabon
hypsignathu
monstrosu
epomop
franquetti
myonycteri
torquata
reston
viru
rna
reportedli
detect
four
bat
speci
captur
philippin
chaerephon
plicatu
cynopteru
brachyoti
miniopteru
australi
miniopteru
schreibersii
yet
infecti
viru
isol
indic
either
deadend
viru
host
clear
viru
infect
prior
sampl
current
filoviru
isol
techniqu
lack
sensit
recov
infecti
viru
specimen
low
viral
load
serolog
reactiv
bat
sera
ebolaviru
antigen
use
indirect
elisa
indirect
fluoresc
test
beadbas
multiplex
assay
andor
western
blot
report
bat
repres
least
speci
throughout
subsaharan
africa
howev
interpret
data
exceedingli
difficult
due
multipl
reason
includ
absenc
panel
posit
neg
bat
sera
initi
serolog
assay
valid
continu
qualiti
control
use
variou
uncharacter
recombin
filoviru
antigen
applic
differ
statist
method
establish
cutoff
valu
seroposit
nonetheless
ebolaviru
serosurveil
offer
sever
distinct
advantag
compar
surveil
activ
viru
infect
includ
longer
diagnost
window
ie
length
time
diagnost
test
detect
evid
infect
knowledg
virustissu
tropism
requir
destruct
sampl
although
erb
natur
reservoir
host
marburgvirus
develop
robust
virusspecif
igg
antibodi
respons
follow
experiment
inocul
studi
gener
high
qualiti
virusspecif
antisera
primeboost
immun
captiv
erb
marburg
viru
ravn
viru
ebola
viru
bundibugyo
viru
forest
viru
sudan
viru
reston
viru
virusspecif
antisera
along
set
bat
sera
use
valid
seri
indirect
elisa
util
nonrecombin
infectiousbas
filoviru
antigen
detect
virusspecif
igg
antibodi
bat
assess
level
serolog
crossreact
virusspecif
antiserum
viral
antigen
use
inform
gener
filoviru
antibodi
fingerprint
abl
predict
six
filoviru
speci
system
antigen
similar
speci
respons
past
infect
bat
use
gener
filovirusspecif
antisera
studi
origin
erb
breed
total
erb
divid
seven
group
tabl
subcutan
inocul
caudal
abdomin
region
isofluran
anesthesia
marburg
viru
ravn
viru
ebola
viru
forest
viru
bundibugyo
viru
sudan
viru
reston
viru
tabl
prepar
ml
steril
dulbecco
modifi
eagl
medium
thermo
fisher
scientif
inc
waltham
usa
eight
week
bat
group
subcutan
challeng
homolog
viru
bat
euthan
two
four
week
thereaft
cardiac
exsanguin
isofluran
anesthesia
follow
overdos
isofluran
whole
blood
collect
serum
separ
tube
fisher
scientif
grand
island
ny
usa
euthanasia
allow
clot
centrifug
g
min
sera
transfer
polypropylen
cryoelit
wheaton
vial
dwk
life
scienc
millvil
nj
usa
temporarili
store
liquid
nitrogen
vapor
biosafeti
level
four
laboratori
doubl
bag
pass
dunk
tank
contain
microchem
plu
nation
chemic
laboratori
incorpor
inc
philadelphia
pa
usa
transport
gammacel
irradi
doublebag
serum
aliquot
sandwich
layer
dri
ice
expos
rad
gammacel
irradi
use
sourc
sera
obtain
bat
breed
coloni
neg
control
bat
previou
experiment
use
sera
sera
collect
process
manner
outlin
anim
procedur
approv
institut
anim
care
use
committe
iacuc
perform
complianc
guid
laboratori
anim
care
use
committe
care
use
laboratori
anim
anim
research
facil
cdc
receiv
full
accredit
associ
assess
accredit
laboratori
anim
care
aaalac
procedur
conduct
filovirus
filovirusinfect
bat
perform
accord
select
agent
regul
anim
plant
health
inspect
servic
center
diseas
control
laboratori
cdc
bat
cage
contain
within
bioflow
isol
unit
hepafilt
inlet
exhaust
air
suppli
duoflow
mobil
unit
lab
product
inc
seaford
de
usa
bat
grouphous
accord
filoviru
inoculum
climat
control
anim
area
h
h
night
cycl
bat
receiv
quantiti
fresh
fruit
supplement
proteinvitamin
powder
equal
bodi
mass
daili
water
ad
libitum
filoviru
antigen
lysat
tabl
uninfect
control
antigen
lysat
filoviru
igg
indirect
elisa
prepar
previous
briefli
roller
bottl
vero
cell
inocul
viru
cultur
harvest
cell
exhibit
evid
infect
immunofluoresc
assay
filoviru
antigen
lysat
prepar
cultur
deterg
basic
buffer
extract
infect
cell
uninfect
control
antigen
lysat
gener
absenc
viru
otherwis
prepar
exact
manner
filovirusspecif
antiserum
n
serum
n
test
reactiv
filoviru
antigen
lysat
n
uninfect
control
antigen
lysat
n
supplementari
fig
well
elisa
plate
coat
dilut
filoviru
antigen
lysat
diluent
pb
contain
thimeros
found
result
optim
reactiv
sera
pool
filovirusinfect
bat
group
ebola
bundibugyo
forest
reston
viru
lysat
marburg
ravn
sudan
viru
lysat
correspond
well
coat
equival
dilut
uninfect
control
lysat
incub
overnight
plate
wash
pb
contain
pbst
serum
diluent
pb
contain
skim
milk
ad
well
plate
min
dilut
gammairradi
bat
serum
predilut
masterpl
diluent
pb
contain
skim
milk
powder
thimeros
ad
first
well
plate
fourfold
serial
dilut
perform
final
bat
serum
concentr
follow
hr
incub
plate
wash
pbst
dilut
goat
antibat
igg
conjug
horseradish
peroxidas
bethyl
laboratori
montgomeri
tx
usa
cat
lot
serum
diluent
ad
plate
manufactur
note
antibodi
react
specif
bat
igg
light
chain
common
immunoglobulin
incub
hr
plate
wash
pbst
twocompon
abt
peroxidas
system
kpl
gaithersburg
md
usa
ad
plate
allow
incub
min
plate
read
micropl
spectrophotomet
set
nm
optic
densiti
od
valu
fourfold
serial
dilut
visual
inspect
ensur
linear
negat
nonspecif
background
reactiv
adjust
od
valu
calcul
subtract
od
fourfold
dilut
well
coat
uninfect
control
antigen
lysat
od
correspond
well
coat
filoviru
antigen
lysat
adjust
sum
od
valu
determin
sum
adjust
od
valu
fourfold
serial
dilut
averag
adjust
sum
od
duplic
run
report
notabl
perform
indirect
elisa
seven
filoviru
antigen
lysat
two
dilut
uninfect
control
antigen
lysat
duplic
requir
serum
breed
coloni
found
ugandan
wildcaught
adult
yr
founder
bat
age
year
determin
subtract
date
captur
date
euthanasia
ad
one
year
bat
born
captiv
age
year
determin
subtract
date
birth
date
euthanasia
bat
classifi
three
age
categori
yr
yr
yr
twoway
anova
perform
determin
serolog
reactiv
bat
sera
homolog
antigen
significantli
influenc
p
sex
age
categori
interact
sex
age
categori
spss
statist
ibm
softwar
armonk
ny
usa
filovirusspecif
igg
indirect
elisa
quadrat
discrimin
analysi
use
determin
cutoff
valu
seroposit
consid
reactiv
filovirusspecif
antisera
group
homolog
antigen
reactiv
sera
group
antigen
prior
probabl
filovirusspecif
antisera
group
vba
microsoft
access
microsoft
offic
profession
plu
redmond
wa
usa
prior
probabl
filovirusspecif
antisera
group
set
valu
repres
overal
popul
seropreval
marburgviru
natur
reservoir
host
assum
seropreval
ebolavirus
respect
natur
reservoir
bat
host
approxim
valu
howev
prior
probabl
rel
littl
influenc
determin
magnitud
cutoff
valu
seroposit
cutoff
valu
filovirusspecif
indirect
elisa
repres
valu
posterior
probabl
reactiv
filovirusspecif
antisera
homolog
antigen
reactiv
sera
antigen
equal
indirect
elisa
specifi
seroposit
cutoff
valu
filovirusspecif
antiserum
serum
sampl
classifi
true
posit
fals
posit
fals
neg
true
neg
sensit
assay
calcul
divid
number
individu
posit
test
result
number
individu
histori
past
infect
experiment
inocul
particular
viru
specif
assay
calcul
divid
number
individu
without
histori
past
infect
group
number
individu
neg
test
result
level
serolog
crossreact
group
filovirusspecif
antisera
heterolog
viru
antigen
calcul
divid
number
antisera
posit
reactiv
viru
antigen
total
number
antisera
test
antigen
eg
number
marburg
viru
antisera
posit
reactiv
ravn
viru
antigennumb
marburg
viru
antisera
test
reactiv
ravn
antigen
express
percentag
nucleotid
sequenc
filoviru
isol
use
inocul
bat
studi
retriev
genbank
code
region
translat
amino
acid
align
use
muscl
algorithm
geneiou
biomatt
limit
auckland
new
zealand
percent
ident
valu
calcul
pairwis
amino
acid
comparison
gener
viru
protein
align
pearson
productmo
correl
perform
assess
relationship
percent
serolog
crossreact
percent
amino
acid
ident
spss
statist
ibm
softwar
armonk
ny
usa
quadrat
discrimin
analysi
use
predict
one
seven
filovirus
system
antigen
similar
filoviru
respons
past
infect
consid
rel
reactiv
filovirusspecif
antiserum
serum
filoviru
antigen
well
covari
visual
basic
microsoft
access
first
prior
probabl
calcul
eight
class
use
analysi
seven
filoviru
antigen
class
one
neg
class
second
classif
perform
calcul
posterior
probabl
inclus
antiserasera
sampl
class
assign
sampl
class
highest
probabl
evalu
abil
system
compris
seven
filovirusspecif
indirect
elisa
predict
filoviru
speci
antigen
similar
speci
respons
past
infect
test
seven
marburg
viru
convalesc
whole
sampl
collect
experiment
inocul
erb
five
sampl
collect
four
week
post
primari
marburg
viru
two
sampl
collect
week
post
primari
inocul
follow
natur
boost
ie
marburg
virusspecif
antibodi
level
wane
bat
increas
follow
contact
infecti
cagem
total
erb
use
studi
perform
twoyear
time
span
total
number
bat
dedic
studi
well
size
composit
group
depend
reproduct
capac
erb
breed
coloni
well
characterist
number
bat
need
experiment
studi
bat
divid
seven
group
group
size
rang
individu
tabl
two
group
bat
approxim
equal
sex
ratio
ravn
forest
two
group
compris
mostli
femal
individu
bundibugyo
sudan
remain
five
group
compris
male
reston
femal
marburg
ebola
individu
two
group
bat
compris
sole
individu
yr
age
bundibugyo
forest
major
individu
three
group
yr
age
marburg
ebola
reston
major
individu
two
group
yr
age
ravn
sudan
despit
observ
variabl
group
composit
twoway
anova
reveal
serolog
reactiv
homolog
filoviru
antigen
significantli
p
influenc
sex
f
age
f
interact
sex
age
f
except
igg
antibodi
indirect
elisa
use
marburg
viru
antigen
sensit
specif
fig
tabl
assay
exhibit
sensit
specif
fig
tabl
mean
group
adjust
sum
od
valu
rang
sd
igg
antibodi
indirect
elisa
use
marburg
viru
antigen
sd
igg
antibodi
indirect
elisa
use
ebola
viru
antigen
figur
tabl
show
level
serolog
crossreact
group
bat
filovirusspecif
antisera
six
heterolog
filoviru
antigen
consist
magnitud
serolog
reactiv
individu
bat
antisera
across
six
heterolog
filoviru
antigen
highlight
robust
perform
filoviru
igg
indirect
elisa
system
strong
serolog
crossreact
observ
marburg
viru
antisera
ravn
viru
antigen
ravn
viru
antisera
marburg
viru
antigen
fig
b
level
serolog
crossreact
ebolaviru
antisera
ebolaviru
antigen
vari
forest
viru
antisera
versu
reston
viru
antigen
bundibugyo
viru
antisera
versu
ebola
viru
antigen
forest
viru
antisera
versu
bundibugyo
viru
antigen
reston
viru
antisera
versu
bundibugyo
forest
viru
antigen
fig
limit
crossreact
observ
marburgviru
antisera
ebolaviru
antigen
major
antiseraantigen
combin
marburg
viru
antisera
versu
forest
viru
antigen
ravn
viru
antisera
versu
bundibugyo
forest
viru
antigen
ravn
viru
antisera
versu
reston
viru
antigen
ebolaviru
antisera
test
marburgviru
antigen
sudan
viru
antisera
versu
marburg
viru
antigen
sudan
viru
antisera
versu
ravn
viru
antigen
fig
pearson
productmo
correl
reveal
statist
signific
strong
posit
correl
percent
filoviru
serolog
crossreact
percent
filoviru
amino
acid
ident
r
n
p
use
adjust
sum
od
data
serum
test
antigen
gener
bat
intent
infect
seven
known
cultur
filovirus
develop
classif
system
fingerprint
predict
filoviru
elicit
antibodi
respons
supplementari
tabl
show
posterior
probabl
support
valu
classif
filovirusspecif
antiserum
serum
sampl
eight
predefin
class
seven
filoviru
antigen
class
one
neg
class
probabl
row
tabl
sum
sampl
assign
class
highest
posterior
probabl
ie
highest
degre
certainti
overal
sampl
correctli
classifi
posterior
probabl
support
true
class
ie
filoviru
use
primeboost
bat
rang
indic
system
use
seven
independ
filoviru
igg
indirect
elisa
abil
establish
antibodi
fingerprint
filoviru
convalesc
bat
sera
use
predict
filoviru
speci
system
antigen
similar
speci
respons
past
infect
see
supplementari
note
exampl
antibodi
fingerprint
perform
studi
assess
perform
predict
abil
filoviru
igg
indirect
elisa
system
test
five
marburg
viru
convalesc
sera
whole
blood
sampl
collect
four
week
post
primari
marburg
viru
experiment
inocul
two
whole
blood
sampl
collect
week
post
primari
experiment
inocul
follow
natur
boost
ie
marburg
virusspecif
antibodi
level
wane
increas
follow
contact
infecti
cagem
expect
marburgvirusspecif
igg
antibodi
level
markedli
lower
seven
convalesc
serum
whole
blood
sampl
compar
marburgvirusspecif
igg
antibodi
level
serum
sampl
primeboost
bat
studi
fig
howev
sampl
collect
primari
marburg
viru
inocul
follow
natur
boost
classifi
marburgviru
igg
antibodi
posit
antibodi
fingerprint
analysi
predict
three
bat
previous
infect
marburg
viru
sampl
id
marburg
posterior
probabl
valu
respect
four
previous
infect
ravn
viru
sampl
id
ravn
posterior
probabl
valu
respect
fig
studi
gener
filovirusspecif
antisera
primeboost
erb
collect
sera
valid
character
indirect
elisa
system
util
nonrecombin
infectiousbas
filoviru
antigen
detect
virusspecif
igg
antibodi
bat
initi
valid
system
reveal
individu
filovirusspecif
igg
indirect
elisa
exhibit
high
sensit
specif
similar
previou
studi
use
human
sera
observ
limit
serolog
igg
crossreact
filoviru
genera
vari
level
serolog
igg
crossreact
ebolaviru
speci
strong
serolog
igg
crossreact
within
speci
marburg
marburgviru
low
level
serolog
igg
crossreact
ebolaviru
speci
underscor
necess
perform
assay
within
system
avoid
fals
neg
result
although
signific
level
serolog
igg
crossreact
observ
primeboost
filovirusspecif
antisera
filoviru
antigen
overal
covari
sevenindividu
indirect
elisa
system
consid
abl
predict
filoviru
speci
respons
past
infect
time
use
littl
sera
serum
test
antigen
duplic
evalu
perform
predict
abil
system
use
seven
marburg
viru
convalesc
serum
whole
blood
sampl
collect
primari
experiment
infect
marburg
viru
primari
experiment
infect
marburg
viru
plu
natur
boost
confirm
system
abl
predict
filoviru
speci
like
respons
past
infect
expect
filoviru
igg
indirect
elisa
system
abl
correctli
predict
whether
past
infect
due
marburg
viru
ravn
viru
time
find
support
current
classif
marburg
ravn
virus
singl
viru
speci
marburg
robust
discriminatori
power
system
result
underli
compon
variou
control
point
employ
infectiousbas
filoviru
antigen
rather
recombin
viru
protein
antigen
strategi
increas
sensit
ie
abil
filoviru
igg
indirect
elisa
system
correctli
identifi
past
exposur
filoviru
filoviru
igg
antibodi
posit
specif
ie
abil
filoviru
igg
indirect
elisa
system
correctli
identifi
past
exposur
filoviru
filoviru
igg
antibodi
neg
system
although
recombin
filoviru
antigen
gener
larg
quantiti
requir
laboratori
product
use
singl
recombin
viru
protein
antibodi
detect
lead
fals
neg
result
individu
antibodi
repertoir
direct
particular
recombin
viru
protein
altern
fals
posit
serolog
result
occur
recombin
viru
antigen
unknowingli
share
similar
epitop
viru
antigen
studi
popul
possess
antibodi
fals
posit
result
also
aris
fail
account
nonspecif
serolog
reactiv
result
presenc
nonviru
contamin
antigen
prepar
negat
nonspecif
serolog
reactiv
vero
cell
compon
subtract
reactiv
well
coat
uninfect
antigen
lysat
reactiv
correspond
well
coat
filoviru
antigen
lysat
major
previous
publish
ebolaviru
serosurvey
bat
use
recombin
filoviru
antigen
gener
bacteri
express
system
studi
implement
procedur
negat
nonspecif
reactiv
residu
bacteri
epitop
antigen
prepar
antibacteri
antibodi
bat
like
major
publish
ebolaviru
serosurvey
bat
perform
serial
serum
dilut
assess
linear
importantli
includ
pool
filovirusspecif
bat
antisera
posit
control
pool
bat
sera
neg
control
everi
run
ensur
filoviru
igg
indirect
elisa
system
continu
perform
expect
use
filovirusspecif
antisera
collect
bat
primeboost
time
allow
us
thoroughli
examin
level
serolog
crossreact
virusspecif
antisera
heterolog
filoviru
antigen
also
provid
opportun
use
knowledg
evalu
previous
publish
ebolaviru
serosurvey
four
previous
publish
ebolaviru
serosurvey
bat
use
ebola
viru
antigen
detect
ebolaviru
igg
anoth
four
serosurvey
use
ebola
reston
antigen
detect
ebolaviru
igg
base
low
serolog
crossreact
ebola
viru
antigen
sudan
viru
antisera
reston
viru
antigen
sudan
viru
antisera
observ
studi
predict
serosurvey
use
ebola
viru
antigen
ebola
reston
viru
antigen
would
miss
opportun
detect
bat
previous
infect
sudan
viru
likewis
due
high
level
serolog
cross
reactiv
ebolavirusspecif
antisera
heterolog
ebolaviru
antigen
observ
studi
possibl
serolog
reactiv
bat
sera
ebola
reston
viru
antigen
previou
serosurvey
due
past
infect
one
known
ebolavirus
undescrib
ebolaviru
although
success
use
quadrat
discrimin
analysi
predict
filoviru
speci
system
antigen
similar
speci
respons
past
infect
nucleotid
sequenc
data
use
ascertain
infect
particular
filoviru
furthermor
incrimin
ebolavirusnatur
reservoir
host
relationship
requir
consist
detect
activ
rna
viru
isol
tissuesbodili
fluid
suggest
transmiss
mechan
past
infect
particular
ebolaviru
space
time
filoviru
igg
indirect
elisa
system
enabl
robust
detect
virusspecif
igg
antibodi
bat
abl
predict
filoviru
speci
like
respons
past
infect
limit
first
system
valid
use
virusspecif
antisera
primeboost
bat
sera
bat
although
seven
marburg
viru
convalesc
whole
blood
serum
sampl
collect
erb
primari
experiment
marburg
viru
inocul
follow
natur
boost
marburgviru
igg
antibodi
posit
sampl
markedli
lower
marburgvirusspecif
igg
antibodi
level
compar
sampl
collect
bat
studi
primeboost
one
seven
filovirus
suggest
sensit
individu
filoviru
igg
indirect
elisa
may
lower
report
use
filovirusspecif
antisera
primeboost
bat
filoviru
bat
sera
howev
statist
determin
seroposit
cutoff
valu
indirect
elisa
larg
driven
varianc
surround
mean
reactiv
sera
viru
antigen
like
circul
longterm
mainten
ebolavirus
natur
reservoir
host
lead
multipl
viru
exposur
throughout
lifetim
individu
result
boost
virusspecif
igg
antibodi
level
natur
boost
virusspecif
igg
antibodi
level
erb
previous
infect
marburg
viru
observ
recent
experiment
transmiss
studi
shortli
document
viru
infect
seroconvers
contact
other
report
period
boost
rabi
viru
neutral
antibodi
titer
wild
coloni
big
brown
bat
eptesicu
fuscu
second
use
goat
antibat
igg
conjug
horseradish
peroxidas
secondari
antibodi
system
antibodi
gener
use
sera
erb
well
sera
nine
bat
speci
compris
four
chiropteran
famili
manufactur
product
datasheet
antibodi
confirm
react
sera
chiropteran
speci
use
success
detect
igg
antibodi
sera
bat
speci
compris
seven
chiropteran
possibl
reactiv
igg
antibodi
diverg
bat
speci
might
diminish
case
concentr
secondari
antibodi
may
need
optim
prior
test
new
speci
bat
altern
secondari
antibodi
may
need
use
third
filoviru
igg
indirect
elisa
system
includ
seven
viru
antigen
repres
report
cultur
filovirus
given
recent
discoveri
filoviru
rna
diverg
bat
famili
geograph
distant
locat
lloviu
viru
miniopteru
schreibersii
famili
miniopterida
bombali
viru
chaerephon
pumilu
famili
molossida
mop
condyluru
famili
molossida
sierra
viru
rousettu
bat
famili
pteropodida
expect
number
undiscov
ebolavirus
continu
circul
natur
howev
believ
genet
divers
ebolaviru
antigen
includ
system
allow
detect
past
infect
novel
ebolaviru
predict
ebolaviru
speci
antigen
similar
speci
respons
past
infect
intend
use
filoviru
igg
indirect
elisa
system
screen
archiv
incom
specimen
crosssect
serosurvey
bat
popul
subsaharan
africa
asia
evid
past
filoviru
infect
specimen
type
exist
bat
speci
identifi
filoviru
seroposit
test
evid
activ
infect
use
virusspecif
qrtpcr
panfiloviru
rtpcr
andor
viru
isol
techniqu
bat
speci
posit
evid
activ
filoviru
infect
speci
exhibit
seropreval
equival
larger
marburgviru
erb
total
popul
seropreval
target
longitudin
studi
aim
collect
wide
rang
specimen
evid
activ
past
ebolaviru
infect
virusspecif
antisera
gener
studi
pool
use
posit
control
indirect
filoviru
elisa
system
reserv
investig
aim
determin
mechan
bat
clear
control
filoviru
infect
viru
neutral
crossneutr
assay
well
epitop
map
studi
remain
filovirusspecif
bat
antisera
may
use
develop
panebolaviru
indirect
elisa
util
mixtur
nonrecombin
infecti
base
antigen
cultur
ebolavirus
well
valid
perform
indirect
elisa
use
recombin
filoviru
protein
detect
filoviru
antibodi
